Your browser doesn't support javascript.
loading
A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate.
Takeuchi, Tsutomu; Tanaka, Yoshiya; Higashitani, Chieri; Iwai, Megumi; Komatsu, Kanji; Akazawa, Rio; Lademacher, Christopher.
Afiliación
  • Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Higashitani C; Clinical Development, Astellas Pharma, Inc., Tokyo, Japan.
  • Iwai M; Clinical Pharmacology and Exploratory Development, Astellas Pharma, Inc., Tokyo, Japan.
  • Komatsu K; Clinical Pharmacology, Astellas Pharma, Inc., Tokyo, Japan.
  • Akazawa R; Data Science, Astellas Pharma, Inc., Tokyo, Japan.
  • Lademacher C; Medical Science, Astellas Pharma, Inc., Northbrook, IL, USA.
Mod Rheumatol ; 31(1): 53-60, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32075475
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Sulfonas / Metotrexato / Hormona Liberadora de Gonadotropina / Posmenopausia / Antirreumáticos / Imidazoles Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Mod Rheumatol Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Sulfonas / Metotrexato / Hormona Liberadora de Gonadotropina / Posmenopausia / Antirreumáticos / Imidazoles Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Mod Rheumatol Año: 2021 Tipo del documento: Article País de afiliación: Japón